参考文献/References:
[1] MAROM G.Esophageal cancer staging[J].Thorac Surg Clin,2022,32(4):437-445.
[2] 夏秀丽,赵树山,李云,等.黄芪多糖对小鼠食管癌前病变的影响及机制研究[J].陕西中医,2022,43(8):1003-1008.
[3] WATERS J K,REZNIK S I.Update on management of squamous cell esophageal cancer[J].Curr Oncol Rep,2022,24(3):375-385.
[4] FANG X,SHRESTHA S M,REN L H,et al.Biological and clinical implications of metastasis-associated circular RNAs in oesophageal squamous cell carcinoma[J].FEBS Open Bio,2021,11(11):2870-2887.
[5] 徐梓凡,郑昊涵,谢田华,等.环状RNA功能及与眼科相关疾病关系研究进展[J].陕西医学杂志,2023,52(5):626-629.
[6] LI T,LI S.Circ_0023984 facilitates esophageal squamous cell carcinoma progression by regulating miR-433-3p/REV3L axis[J].Dig Dis Sci,2022,67(3):892-903.
[7] GUO C,MI J,LI H,et al.Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma:A meta-analysis[J].Cancer Med,2021,10(22):7895-7908.
[8] WANG J,ZHANG R,ZHANG B,et al.MiR-135b improves proliferation and regulates chemotherapy resistance in ovarian cancer[J].J Mol Histol,2022,53(4):699-712.
[9] JAJOSKY A,FELS ELLIOTT D R.Esophageal cancer genetics and clinical translation[J].Thorac Surg Clin,2022,32(4):425-435.
[10] 陈博,李涛.清热消滞抗癌方联合放疗对食管癌患者4-羟基壬烯醛、糖类抗原199的影响[J].陕西中医,2022,43(12):1749-1752.
[11] 张新伟,王瑞洁,张曦,等.帕博利珠单抗联合新辅助化疗治疗Ⅱ、Ⅲ期食管癌临床疗效[J].陕西医学杂志,2022,51(7):870-873.
[12] CHEN J,YANG J,FEI X,et al.CircRNA ciRS-7:A novel oncogene in multiple cancers[J].Int J Biol Sci,2021,17(1):379-389.
[13] ZANG H L,JI F J,JU H Y,et al.Circular RNA AKT3 governs malignant behaviors of esophageal cancer cells by sponging miR-17-5p[J].World J Gastroenterol,2021,27(3):240-254.
[14] ZHOU S,GUO Z,LV X,et al.CircGOT1 promotes cell proliferation,mobility,and glycolysis-mediated cisplatin resistance via inhibiting its host gene GOT1 in esophageal squamous cell cancer[J].Cell Cycle,2022,21(3):247-260.
[15] CHEN X,SUN H,ZHAO Y,et al.CircRNA circ_0004370 promotes cell proliferation,migration,and invasion and inhibits cell apoptosis of esophageal cancer via miR-1301-3p/COL1A1 axis[J].Open Med(Wars),2021,16(1):104-116.
[16] FANG J,JI W H,WANG F Z,et al.Circular RNA hsa_circ_0000700 promotes cell proliferation and migration in esophageal squamous cell carcinoma by sponging miR-1229[J].J Cancer,2021,12(9):2610-2623.
[17] YUE M,LIU Y,ZUO T,et al.Circ_0006948 contributes to cell growth,migration,invasion and epithelial-mesenchymal transition in esophageal carcinoma[J].Dig Dis Sci,2022,67(2):492-503.
[18] LIU Z H,YANG S Z,LI W Y,et al.CircRNA_141539 can serve as an oncogenic factor in esophageal squamous cell carcinoma by sponging miR-4469 and activating CDK3 gene[J].Aging(Albany NY),2021,13(8):12179-12193.
[19] GAO C,XU Y J,QI L,et al.CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis[J].Cell Biol Toxicol,2022,38(5):825-845.
[20] WANG J,CHEN Y,WU R,et al.Circular RNA hsa_circ_0000554 promotes progression and elevates radioresistance through the miR-485-5p/fermitin family members 1 axis in esophageal cancer[J].Anticancer Drugs,2021,32(4):405-416.
[21] TANG R,ZHOU Q,XU Q,et al.Circular RNA circ_0006948 promotes esophageal squamous cell carcinoma progression by regulating microRNA-3612/LASP1 axis[J].Dig Dis Sci,2022,67(6):2158-2172.
[22] ZHU H,DU F,CAO C.Restoration of circ-PSMC3 sensitizes gefitinib-resistant esophageal squamous cell carcinoma cells to gefitinib by regulating miR-10a-5p/PTEN axis[J].Cell Biol Int,2021,45(1):107-116.
[23] LIU D,JIN Y,WU J,et al.MiR-135b-5p is an oncogene in pancreatic cancer to regulate GPRC5A expression by targeting transcription factor KLF4[J].Cell Death Discov,2022,8(1):23.
[24] ZHAO J,WANG X,MI Z,et al.STAT3/miR-135b/NF-κB axis confers aggressiveness and unfavorable prognosis in non-small-cell lung cancer[J].Cell Death Dis,2021,12(5):493.
[25] LU M,HUANG Y,SUN W,et al.MiR-135b-5p promotes gastric cancer progression by targeting CMTM3[J].Int J Oncol,2018,52(2):589-598.
[26] DI Y,JIANG Y,SHEN X,et al.Downregulation of miR-135b-5p suppresses progression of esophageal cancer and contributes to the effect of cisplatin[J].Front Oncol,2021,11:679348.
相似文献/References:
[1]胡珊珊,宋 彦,罗玉明,等.食管内放射支架对中晚期食管癌患者吞咽困难疗效及预后影响[J].陕西医学杂志,2019,(1):83.
HU Shanshan,SONG Yan,LUO Yuming,et al.Effect of esophageal stent on dysphagia and prognosis in patients with advanced esophageal cancer[J].,2019,(3):83.
[2]魏晓华,郭俊霞.不同内镜技术在食管癌及癌前病变筛查中的应用价值研究*[J].陕西医学杂志,2019,(5):591.
WEI Xiaohua,GUO Junxia..Application value of different endoscopy techniques in the screening of esophageal cancer and precancerous lesions[J].,2019,(3):591.
[3]马显平,张海斌.叉头框转录因子M1和增殖细胞核抗原在食管癌组织中的表达及与放化疗预后相关性分析[J].陕西医学杂志,2021,50(9):1150.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.027]
MA Xianping,ZHANG Haibin.Expression of FOXM1 and PCNA in esophageal carcinoma and their correlation with prognosis of radiotherapy and chemotherapy[J].,2021,50(3):1150.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.027]
[4]何 芸,张卫卫,孔祥云.血清白细胞介素-6、肿瘤坏死因子-α、活性氧在食管癌术后并发心房颤动患者体内表达水平及检测意义[J].陕西医学杂志,2022,51(7):816.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.011]
HE Yun,ZHANG Weiwei,KONG Xiangyun.Expression level and significance of serum IL-6,TNF-α and reactive oxygen species in patients with atrial fibrillation after esophageal cancer surgery[J].,2022,51(3):816.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.011]
[5]张新伟,王瑞洁,张 曦,等.帕博利珠单抗联合新辅助化疗治疗Ⅱ、Ⅲ期食管癌临床疗效[J].陕西医学杂志,2022,51(7):870.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.025]
ZHANG Xinwei,WANG Ruijie,ZHANG Xi,et al.Clinical efficacy of pembrolizumab combined with neoadjuvant chemotherapy in treatment of stage Ⅱ and Ⅲ esophageal cancer[J].,2022,51(3):870.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.025]
[6]周 敏,张艳霞,郭 楠,等.甲磺酸阿帕替尼对裸鼠食管癌的抗肿瘤作用及机制研究[J].陕西医学杂志,2023,52(12):1670.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.009]
ZHOU Min,ZHANG Yanxia,GUO Nan,et al.Antitumor effect and mechanism of apatinib mesylate on esophageal cancer in nude mice[J].,2023,52(3):1670.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.009]
[7]万传科,王晓霞,张彦青,等.川陈皮素对食管癌KYSE150细胞存活、侵袭和凋亡的影响及机制实验研究[J].陕西医学杂志,2024,(3):407.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.026]
WAN Chuanke,WANG Xiaoxia,ZHANG Yanqing,et al.Effects of nobiletin on survival,invasion and apoptosis of esophageal carcinoma KYSE150 cells and its mechanism[J].,2024,(3):407.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.026]
[8]张少锋,李丹青,杜 凡,等.食管癌术后重症肺炎患者血清肺表面活性物质相关蛋白质-D、高迁移率族蛋白B1和中性粒细胞与淋巴细胞比值水平变化及检测意义[J].陕西医学杂志,2024,(8):1114.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.024]
ZHANG Shaofeng,LI Danqing,DU Fan,et al.Changes and detection significance of serum pulmonary surfactant associated protein,high mobility group box 1 protein and neutrophil-to-lymphocyte ratioin patients with severe pneumonia after esophageal cancer surgery[J].,2024,(3):1114.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.024]
[9]符梦婕,张 剑,李秋忆,等.长链非编码RNA淋巴细胞白血病缺失基因2/微小RNA-30c-5p/丝裂原活化蛋白激酶1轴在食管癌细胞紫杉醇耐药中的作用机制实验研究[J].陕西医学杂志,2024,(9):1155.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.001]
FU Mengjie,ZHANG Jian,LI Qiuyi,et al.Mechanism of lncRNA DLEU2/miR-30c-5p/MAPK1 axis in paclitaxel resistance in esophageal cancer cells[J].,2024,(3):1155.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.001]
[10]王银燕,黄 翠,朱 艳,等.长链非编码RNA UBE2Q1-AS1对食管癌细胞增殖和迁移的调节作用及机制实验研究[J].陕西医学杂志,2024,(9):1172.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.004]
WANG Yinyan,HUANG Cui,ZHU Yan,et al.Regulatory effect and mechanism of lncRNA UBE2Q1-AS1 on proliferation and migration of esophageal cancer cells[J].,2024,(3):1172.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.004]